Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by mercedesmanon Jul 21, 2021 3:56pm
151 Views
Post# 33582646

Finally !!

Finally !!Board unity !

Who knew it was possible?


Maybe it took them going just a little bit too far !
  • No pre-mention of financing (except Dialco spin-out to establish value of that peice)
  • No reasonable/articulated justification for the sudden $ raise.... Tigris way behind schedule, so why are $ needed all of a sudden? Wasn't Baxter's money for Tigris Trial completion? (with more coming if they like what they see at Interim)
  • Lackluster effort (PR) compared to peers...despite seemingly much better fundamentals (comparatively speaking - by any objective measure).
  • Why seemingly lots of institutional (behind the scenes?) interest being generated, but almost zero retail interest (other than from existing shareholders that are somewhat educated on the history and potential) ?
  • if there are institutions interested in the story (for two bits and a song) then it shouldn't be that difficult to generate retail interest...if only t better set the price to instituions.
  • why financing at a 20% + discount to recent trading price plus sweeteners that are also below recent trading price?
  • Nasdaq (talk for 3 years - no action)
  • mega Dilution with lots of hidden sweetners/commissions
  • guessing the miraculously fully subscribed over night financing, includes some insiders.  Where all shareholders offered even a chance? As a retailer, try to get some - I dare you.
  • No independent analysts on-board despite great science and a geat story potential.
  • Options, warrants, options, warrants, options, warrants.

<< Previous
Bullboard Posts
Next >>